Abstract

INTRODUCTION:Blood borne viral infections (hepatitis C, hepatitis B, human immune deficiency virus), constitute a significant public health concern among patients with opioid dependence, especially among intravenous drug users (IDU).AIM:To measure the prevalence of hepatitis C among patients with intravenous opioid dependence, visiting de-addiction clinic, in a tertiary care hospital in the state of Himachal Pradesh.MATERIAL AND METHOD:A cross-sectional study was conducted between January 2021 and June 2021 at de-addiction clinic, department of Psychiatry, IGMC, Shimla. Socio-demographic and clinical profiles of patients with diagnosis of opioid dependence was entered in a pre-structured performa. All these patients were investigated for HCV antibody using ELISA (enzyme linked immunoassay) test.RESULTS:The study sample comprised of 200 male patients, and majority were between age 21-40 years (96.5%), from nuclear families (57%), urban background (56.5%). One fourth (25.5%) reported suicidal ideation/attempt. Intravenous mode of drug use (IDU) was reported by 121 (60.5%) patients, and majority were from nuclear families (64.46%), urban background (49.59%), and 30.58% reported suicidal ideation/attempt. 29 patients (23.97%) tested positive for hepatitis C infection.CONCLUSION:There is high rate of hepatitis C infection among patients with opioid (intravenous) dependence, at our de-addiction clinic. Future studies with large sample size exploring the high risk behaviour practices and studies with longitudinal design to assess treatment retention, are needed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call